Methods, systems, and media for event pattern treatment recommendations are provided. In some embodiments, a method involve identifying a plurality of event patterns within a plurality of monitoring periods based on measurement values of a physiological condition. The techniques may involve causing display of a snapshot graphical user interface display, wherein the snapshot graphical user interface display comprises a graph overlay region and an event detection region, the graph overlay region comprises a graphical representation of the measurement values, and the event detection region comprises a pattern guidance display for at least a subset of the plurality of event patterns, wherein the pattern guidance display for at least one event pattern includes a graphical representation of a recommended therapeutic remedial action that comprises therapy parameters, to be used by a medical device during a subsequent time period, configured to mitigate occurrence of the at least one event pattern.

A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”). The incidence of severe and significant hypoglycemia reduced 2300- and 200-fold, respectively, during simulated overnight closed-loop control with the MPC algorithm using the glucose measurement error model suggesting that the continuous glucose monitoring technologies facilitate safe closed-loop insulin delivery.

The drug administration quantitative management assisting system includes an inputter and a calculator. The inputter receives, as input data, a time passed from previous drug administration to a patient and/or a value of biological materials in blood of the patient and/or a change of the value. The calculator calculates probabilities of drug administration to the patient as trinary determination of the dosage direction of STAY, UP or DOWN on the basis of a calculation model, and a first determination for determining the dosage direction, and a second determination for determining the dosage direction of UP or DOWN if the first determination is NON-STAY. The calculation model is prepared by machine learning using, as training data, the time passed from previous drug administration to a plurality of patients and/or the value of the biological material in blood of the plurality of patients and/or the changes of the value, and data indicating, as previous determination of the drug administration to the plurality of patients determined by doctors, any one of the dosage directions.

An infusion pump assembly includes a reservoir assembly configured to contain an infusible fluid. A motor assembly is configured to act upon the reservoir assembly and dispense at least a portion of the infusible fluid contained within the reservoir assembly. Processing logic is configured to control the motor assembly. The processing logic includes a primary microprocessor configured to execute one or more primary applications written in a first computer language; and a safety microprocessor configured to execute one or more safety applications written in a second computer language.

The present disclosure relates to a drug delivery system and to a drug delivery device, the drug delivery device comprising: a receptacle to accommodate a drug container, wherein the drug container is provided with a container identification, the container identification being at least indicative of a content of the drug container, a container identification arrangement configured to detect and/or to identify the container identification, a delivery device interface configured to transmit uplink data to a communication device, wherein the uplink data contains at least the container identification obtainable from the container identification arrangement and wherein the delivery device interface is configured to receive downlink data from the communication device, and a drive mechanism operably engageable with the drug container and configured to expel a dose of the drug from the drug container on the basis of the downlink data received from the delivery device interface.

An apparatus comprising a user interface configured to generate an electrical signal to start a basal insulin rate test when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration during delivery of insulin according to a specified basal insulin rate pattern, and a controller communicatively coupled to the input and the user interface. The controller includes an insulin calculation module configured for determining at least one of an amount of basal insulin over-delivered and an amount of basal insulin under-delivered during the basal insulin rate test in trying to meet a target blood glucose baseline. Other devices and methods are disclosed.

An apparatus comprising a user interface configured to generate an electrical signal to start a basal insulin rate test when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration during delivery of insulin according to a specified basal insulin rate pattern, and a controller communicatively coupled to the input and the user interface. The controller includes an insulin calculation module configured for determining at least one of an amount of basal insulin over-delivered and an amount of basal insulin under-delivered during the basal insulin rate test in trying to meet a target blood glucose baseline. Other devices and methods are disclosed.

An infusion pump assembly includes a reservoir assembly configured to contain an infusible fluid. A motor assembly is configured to act upon the reservoir assembly and dispense at least a portion of the infusible fluid contained within the reservoir assembly. Processing logic is configured to control the motor assembly. The processing logic includes a primary microprocessor configured to execute one or more primary applications written in a first computer language; and a safety microprocessor configured to execute one or more safety applications written in a second computer language.

A solution is proposed for operating an injection system comprising a pressurizing unit and at least one supply station for supplying a medical fluid to the pressurizing unit, the supply station comprising at least one receptacle for containing said medical fluid, a delivery arrangement in fluid communication with the receptacle and the pressurizing unit for delivering the medical fluid to a patient, and clamping means associated with the delivery arrangement for regulating the flow of the medical fluid through the delivery arrangement. The method comprises the steps of: operating the pressurizing unit till a first injection procedure is completed; maintaining the injection system in a standby condition before a second injection procedure is started, and operating the pressurizing unit till the second injection procedure is completed. The step of maintaining the injection system in a standby condition comprises the step of acting on the clamping means for de-clamping the delivery arrangement.

A solution is proposed for operating an injection system comprising a pressurizing unit and at least one supply station for supplying a medical fluid to the pressurizing unit, the supply station comprising at least one receptacle for containing said medical fluid, a delivery arrangement in fluid communication with the receptacle and the pressurizing unit for delivering the medical fluid to a patient, and clamping means associated with the delivery arrangement for regulating the flow of the medical fluid through the delivery arrangement. The method comprises the steps of: operating the pressurizing unit till a first injection procedure is completed; maintaining the injection system in a standby condition before a second injection procedure is started, and operating the pressurizing unit till the second injection procedure is completed. The step of maintaining the injection system in a standby condition comprises the step of acting on the clamping means for de-clamping the delivery arrangement.